Sunday, February 03, 2019 12:35:16 PM
The ”Going Concern” statement within their filings is of no major concern in my opinion. Most companies that are ”fully reporting” and file with the SEC on a regular basis have some kind of a ”going concern” statement or warning within their filings. This is nothing more than a formality that’s delivered as a safety precaution that companies use as a way to cover them for a “worst case scenario” situation if for some reason their company does not execute their business objectives and to be legally protected.
The ”going concern” statements that you see in numerous filings is also a way for a company to remain very conservative to make sure they don’t get into any trouble if for any reason anything within their filings or PRs are considered too forward thinking where shareholders could have felt that they might have been misled by the company.
I can tell you numerous stocks that have had major moves, all while having a Going concern Statement listed within their filings. It’s nothing more than a company being conservative in nature. This is why I think it is important to understand the intent behind such conservatism when these statements are within a company’s filings.
I’m not saying to ignore any “going concern” warnings within any company’s filings, but I am saying that they do not pose a negative threat that some might perceive.
Doing your own research and knowing what you hold is the solution to have a better understanding of just how important a “going concern” really is. After doing my own research… I have zero concerns here with VYST.
I think we will be better than fine here in VYST.
v/r
Sterling
Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531
I never give investing advice; only my beliefs for risks in a stock.
Recent VYST News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 08:06:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 11:01:23 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 10:21:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 07:36:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:46:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/26/2023 06:41:50 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/10/2023 09:14:55 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM